International Journal of Gynecology & Obstetrics
Volume 91, Issue 3 , Pages 221-227 , December 2005

Calcium plus linoleic acid therapy for pregnancy-induced hypertension

  • J.A. Herrera

      Affiliations

    • Department of Family Medicine, School of Medicine, Universidad del Valle, Cali, Colombia
  • ,
  • A.K.M. Shahabuddin

      Affiliations

    • Institute of Child and Mother Health, Dhaka, Bangladesh
  • ,
  • G. Ersheng

      Affiliations

    • Shanghai Institute of Planned Parenthood Research, Shanghai, China
  • ,
  • Yuan Wei

      Affiliations

    • Shanghai Institute of Planned Parenthood Research, Shanghai, China
  • ,
  • R.G. Garcia

      Affiliations

    • Fundación Cardiovascular de Colombia, Bucaramanga, Colombia
  • ,
  • P. López-Jaramillo

      Affiliations

    • Fundación Cardiovascular de Colombia, Bucaramanga, Colombia
    • Corresponding Author InformationCorresponding author. Calle 155a # 23-58, 3rd Floor, Instituto de Investigaciones, Fundación Cardiovascular, Floridablanca, Colombia. Tel.: +57 7 6399292x308 331; fax: +57 7 6392744.

Received 8 June 2005 ,Revised 30 August 2005 ,Accepted 30 August 2005.

References 

  1. Walker JJ. Pre-eclampsia. Lancet. 2000;356:1260–1265
  2. World Health Organization . World Health Organization international collaborative study of hypertensive disorders of pregnancy: geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol. 1988;158:80–83
  3. López-Jaramillo P, Garcia RG, López M. Preventing pregnancy induced hypertension: are there regional differences for this global problem?. J Hypertens. 2005;23:1121–1129
  4. López-Jaramillo P, Casas JP, Serrano NC. Preeclampsia: from epidemiological observations to molecular mechanism. Braz J Med Biol Res. 2001;34:1227–1235
  5. López-Jaramillo P. Calcium, nitric oxide, and preeclampsia. Sem Perinatol. 2000;24:33–36
  6. López-Jaramillo P, Terán E, Moncada S. Calcium supplementation prevent pregnancy-induced hypertension by increasing the production of vascular nitric oxide. Med Hypotheses. 1995;45:68–72
  7. López-Jaramillo P, Narváez M, Weigel M, Yépez R. Calcium supplementation reduces the risk of pregnancy induced hypertension in an Andean population. Br J Obstet Gynaecol. 1989;96:648–655
  8. López-Jaramillo P, Narváez M, Félix C, López A. Dietary calcium supplementation and prevention of pregnancy hypertension. Lancet. 1990;335:293–298
  9. López-Jaramillo P, Delgado F, Jácome P, Terán E, Ruano C, Rivera J. Calcium supplementation reduces the risk of preeclampsia in Ecuadorian pregnant teenagers. Obstet Gynecol. 1997;90:162–167
  10. Herrera JA. Nutritional factors and lateral rest reduce pregnancy-induced hypertension in positive roll-over test primigravids. Int J Obstet Gynecol. 1993;41:31–35
  11. Herrera JA, Arévalo-Herrera M, Herrera S. Prevention of preeclampsia by linoleic acid and calcium supplementation. Obstet Gynecol. 1998;91:585–590
  12. Belizan JM, Villar J, González L, Campodonico L, Bergel E. Calcium supplementation to prevent hypertensive disorders of pregnancy. N Engl J Med. 1991;325:1399–1405
  13. Purwar M, Kulkarni H, Motghare V, Dhole S. Calcium supplementation and prevention of pregnancy induced hypertension. J Obstet Gynaecol Res. 1996;22:425–430
  14. Levine RJ, Aut JC, Curet LB, Sibai BM, Catalano PM, Morris CD, et al. Trial of calcium for prevention of preeclampsia. N Engl J Med. 1997;337:69–76
  15. Atallah AN, Hofmeyr GJ, Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems (Cochrane Review). Chichester, UK: John Wiley and Sons, Ltd. Cochrane Library; 2004. issue 1.
  16. Zimmermann P, Eirio V, Koskinen J, Kujansuu E, Ranta T. Doppler assessment of the uterine and uteroplacental circulation in the second trimester in pregnancies at high risk for preeclampsia and for intrauterine growth retardation: comparison and correlation between different Doppler parameters. Ultrasound Obstet Gynecol. 1997;9:330–338
  17. Accini JL, Sotomayor A, Trujillo F, Barrera JG, Bautista L, López-Jaramillo P. Colombian study to assess the use of noninvasive determination of endothelium-mediated vasodilatation (CANDEV): normal values and factors associated. Endothelium. 2001;8:157–166
  18. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39:257–265
  19. Working Group on High Blood Pressure in Pregnancy . Report of the national high blood pressure education program working group on high blood pressure in pregnancy. Am J Obstet Gynecol. 2000;183:S1–S22(suppl)
  20. Pitkin RM. Calcium metabolism in pregnancy and the perinatal period; a review. Am J Obstet Gynecol. 1985;151:99–109
  21. López-Jaramillo P, González MC, Palmer RM. The crucial role of physiological Ca2+ concentrations in the production of endothelial nitric oxide and the control of vascular tone. Br J Pharmacol. 1990;101:489–493
  22. Herrera JA, Chaudhuri G, López-Jaramillo P. Is infection a major risk for preeclampsia?. Med Hypotheses. 2001;57:393–397
  23. Hsu CD, Witter FR. Urogenital Infection in preeclampsia. Int J Gynecol Obstet. 1995;49:271–275
  24. Hill JA, Devoe LD, Bryans JR. Frequency of asymptomatic bacteriuria in preeclampsia. Obstet Gynecol. 1986;67:529–532

PII: S0020-7292(05)00484-4

doi: 10.1016/j.ijgo.2005.08.018

International Journal of Gynecology & Obstetrics
Volume 91, Issue 3 , Pages 221-227 , December 2005